Background
Patients with ductal carcinoma in situ (DCIS) are at increased risk
for developing contralateral breast cancer (CBC). Consequently, more women
with DCIS are electing contralateral prophylactic mastectomy (CPM). We
evaluated factors associated with CPM in patients with DCIS who underwent
genetic counseling for BRCA testing.
Methods
This retrospective study involved 165 women with DCIS referred for
genetic counseling between 2003 and 2011. Patient characteristics were age,
marital and educational status, tumor markers, nuclear grade, family history
of breast cancer (BC) and ovarian cancer (OC), race, Ashkenazi Jewish
ancestry, and BRCA results. Univariate and multivariate
logistic regression analyses were used to determine predictive factors
associated with CPM election.
Results
Of 165 patients, 44 (27%) underwent CPM. Patients <
45 years were more likely to elect CPM (P = .0098).
A BRCA+ mutation was found in 17 patients
(10.3%), and BRCA+ women were more likely to elect CPM than
BRCA- or untested women (P = 0.0001). Patients who
had a family history of OC (57.7%) were more likely to choose CPM
than those with no family history (P = 0.0004).
Younger age, BRCA+, and an OC family history
remained significant in the multivariate model (P <
0.008).
Conclusion
The CPM rate among patients with DCIS who undergo genetic counseling
is high. Factors associated with increased likelihood of CPM among this
group were age, BRCA+, and a family history of OC.
Further studies are needed to evaluate patients' perceptions of CBC
risk and their role in the likelihood of CPM choice.